Clovis Oncology (CLVS) increases its stock offering to $240M from $170M, selling 3.33M shares at...


Clovis Oncology (CLVS) increases its stock offering to $240M from $170M, selling 3.33M shares at $72 each. There's also a greenshoe option of 486,110 shares. Clovis intends to use the money for general corporate purposes, including funding the company's development programs, and the acquisition or licensing of additional product candidates or businesses. Shares -2.1% at $73.30. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs